ADORA3 and Cough: The investigation revealed that AG NPP709 effectively inhibits tachykinin NK1, NK2, phosphodiesterase 4B (PDE4B), and adenosine A3 receptors, which are implicated in airway smooth muscle contraction, a key factor in cough pathogenesis.